GO:0031663 lipopolysaccharide-mediated signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031663 describes the molecular signaling cascade triggered when lipopolysaccharide (LPS) binds to receptors on target cells, culminating in regulation of downstream processes such as transcription.
• The canonical LPS receptor complex includes TLR4, CD14, and MD-2, which together initiate NF-κB and MAPK signaling.
• LPS-mediated signaling is a cornerstone of innate immunity and is implicated in acute lung injury, inflammatory diseases, and metabolic disorders.
• Key downstream effectors include NF-κB, Akt-mTOR, and purinergic P2 receptors, which modulate cytokine expression and cellular metabolism.
• Experimental models for studying this pathway include knockout mice, point-mutant cell lines, and CRISPR knock-in reporters for real-time signaling visualization.
• EDITGENE provides CRISPR services to interrogate every node of the LPS signaling network, from receptor knockout to overexpression models.
Description
The lipopolysaccharide-mediated signaling pathway (GO:0031663) is a fundamental biological process by which cells sense and respond to lipopolysaccharides (LPS), major components of the outer membrane of Gram-negative bacteria. This pathway begins with the binding of LPS to cell surface receptors, notably the Toll-like receptor 4 (TLR4)/CD14/MD-2 complex, and ends with the regulation of downstream cellular processes such as transcription of pro-inflammatory genes. Understanding this pathway is critical for immunology, infectious disease, and inflammation research, as it orchestrates innate immune responses and contributes to pathologies ranging from acute lung injury to metabolic dysfunction. Researchers study GO:0031663 to identify therapeutic targets for sepsis, chronic inflammation, and autoimmune conditions. The pathway is highly conserved and serves as a model for receptor-mediated signaling in general.
lipopolysaccharide-mediated signaling pathway At A Glance
| GO ID | GO:0031663 |
|---|---|
| GO term | lipopolysaccharide-mediated signaling pathway |
| Ontology | biological_process |
| Synonym | LPS-mediated signaling pathway; lipopolysaccharide-mediated signalling pathway |
| Major function | Initiates innate immune responses to Gram-negative bacteria via receptor binding and downstream transcription regulation |
| Key receptors | TLR4, CD14, MD-2 (LY96) |
| Downstream effectors | NF-κB, MAPKs, Akt-mTOR, P2 purinoceptors |
| Cellular context | Macrophages, endothelial cells, adipocytes, dental pulp cells, microglia |
What Is GO:0031663?
GO:0031663, lipopolysaccharide-mediated signaling pathway, is defined as the series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
Why Is lipopolysaccharide-mediated signaling pathway Important in Cell Biology?
GO:0031663 is essential for host defense against Gram-negative bacterial infections and is a central driver of inflammation. Dysregulation of this pathway contributes to acute lung injury, sepsis, insulin resistance, and neuroinflammation. It is also a key target for anti-inflammatory drug development and for understanding how cells integrate microbial cues into transcriptional programs.
• Mediates innate immune recognition of Gram-negative bacteria.
• Activates NF-κB and MAPK cascades, leading to cytokine production.
• Implicated in acute lung injury and pulmonary inflammation.
• Plays a role in endothelial dysfunction and vascular inflammation.
• Regulates interleukin-6 mRNA expression via ATP signaling in dental pulp cells.
• Modulates microglial activation and neurotoxicity.
• Links postprandial glycemia to adipose tissue macrophage signaling.
• Involved in pyroptosis of nucleus pulposus mesenchymal stem cells.
• Contributes to kidney necroptosis and mitochondrial dynamics imbalance.
• Serves as a model for receptor-mediated signaling and drug discovery.
What Happens During lipopolysaccharide-mediated signaling pathway?
LPS Recognition and Receptor Binding
In simple terms: LPS from bacteria is detected by a receptor complex on the cell surface.
The pathway begins when LPS binds to the TLR4/CD14/MD-2 receptor complex on the surface of target cells, such as macrophages. CD14 facilitates the transfer of LPS to TLR4, while MD-2 is essential for TLR4 activation. This binding event triggers receptor dimerization and recruitment of adaptor proteins.
Intracellular Signaling Cascade Activation
In simple terms: The receptor sends a signal inside the cell through a chain of proteins.
Upon activation, TLR4 recruits adaptor proteins such as MyD88 and TRIF, leading to activation of downstream kinases including IRAKs and TAK1. This cascade results in the phosphorylation and activation of NF-κB and MAPK pathways. Additionally, ATP-mediated signaling via P2 purinoceptors can modulate this cascade in specific cell types.
Transcription Factor Activation and Gene Expression
In simple terms: Signals reach the nucleus and turn on inflammatory genes.
NF-κB translocates to the nucleus and drives transcription of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. In dental pulp cells, LPS-mediated ATP signaling regulates IL-6 mRNA expression through P2-purinoceptor activation. This transcriptional response is a hallmark of the pathway's endpoint.
Crosstalk with Metabolic and Cell Death Pathways
In simple terms: LPS signaling also affects metabolism and cell survival.
LPS-mediated signaling intersects with Akt-mTOR activation in adipose tissue macrophages, influencing postprandial glycemia. It can also induce pyroptosis via RhoA signaling in nucleus pulposus mesenchymal stem cells and trigger necroptosis through TLR4/RIPK3/DRP1 in kidney cells. These crosstalks expand the pathway's physiological impact.
Resolution and Negative Feedback
In simple terms: The cell has ways to shut down the signal to avoid damage.
Negative regulators such as A20 and SOCS proteins attenuate LPS signaling to prevent excessive inflammation. Dysregulation of these feedback mechanisms can lead to chronic inflammatory diseases. Understanding resolution is key for therapeutic targeting.
Key Genes Involved in GO:0031663 lipopolysaccharide-mediated signaling pathway
The following genes and proteins are central to the lipopolysaccharide-mediated signaling pathway, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | LPS receptor; initiates signaling | Knockout models for sepsis and inflammation |
| CD14 | Co-receptor for LPS binding | Point mutations affect LPS sensitivity |
| LY96 (MD-2) | Essential for TLR4 activation | Knock-in reporters for receptor dynamics |
| NFKB1 | Transcription factor; drives cytokine expression | KO mice for acute lung injury |
| MAPK1/3 | Kinases downstream of TLR4 | Phospho-specific antibodies for pathway mapping |
| AKT1 | Metabolic signaling node | Adipose macrophage studies |
| MTOR | Integrates LPS and insulin signaling | Postprandial glycemia models |
| P2RY2 | Purinergic receptor; modulates IL-6 | Dental pulp cell studies |
| WNT1 | Microglial activation modulator | Neuroinflammation models |
| GDF5 | Inhibits pyroptosis via RhoA | Nucleus pulposus stem cells |
| RHOA | Mediates GDF5 effects | Pyroptosis research |
| RIPK3 | Necroptosis effector | Kidney injury models |
| DRP1 | Mitochondrial dynamics regulator | Necroptosis and inflammation |
| TRPV1 | Interacts with TLR4/CD14 | Macrophage inflammation |
| IL6 | Pro-inflammatory cytokine | Readout of pathway activation |
| TNF | Pro-inflammatory cytokine | Acute lung injury models |
| CXCL8 | Chemokine; neutrophil recruitment | Endothelial inflammation |
How Is lipopolysaccharide-mediated signaling pathway Regulated?
The lipopolysaccharide-mediated signaling pathway is tightly regulated at multiple levels. Negative feedback loops involving A20, SOCS1, and IRAK-M dampen TLR4 signaling to prevent excessive inflammation. Post-translational modifications such as phosphorylation and ubiquitination control the stability and activity of key signaling intermediates. Crosstalk with metabolic pathways, including Akt-mTOR, modulates the intensity and duration of LPS responses in adipose tissue macrophages. Additionally, purinergic signaling via P2 receptors can amplify or attenuate specific outputs such as IL-6 expression. Dysregulation of these control mechanisms contributes to inflammatory diseases.
lipopolysaccharide-mediated signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NFKB1 | Acute lung injury | Knockout mice with LPS challenge |
| AKT1 | Insulin resistance | Adipose-specific knockout |
| WNT1 | Neuroinflammation | Microglial overexpression |
| GDF5 | Intervertebral disc degeneration | Mesenchymal stem cell knock-in |
| RIPK3 | Kidney necroptosis | Point-mutant mice |
Acute Lung Injury and Sepsis
LPS-mediated signaling is a major driver of acute lung injury, where excessive NF-κB activation leads to cytokine storm and tissue damage. Topotecan has been shown to alleviate LPS-mediated acute lung injury by inhibiting NF-κB signaling. Targeting this pathway is a therapeutic strategy for sepsis and ARDS.
Vascular Inflammation and Atherosclerosis
In endothelial cells, LPS triggers inflammatory reactions through NF-κB, contributing to vascular dysfunction. N-acetyl cysteine protects HUVECs against LPS-mediated inflammation by blocking this pathway. This highlights the pathway's role in cardiovascular complications of infection.
Neuroinflammation and Neurodegeneration
Microglial activation by LPS involves Wnt1 and Wnt/LRP5/6 signaling, linking the pathway to neurotoxicity. TRPV1 interaction with TLR4/CD14 further modulates macrophage inflammation in the nervous system. These findings suggest roles in neurodegenerative diseases.
Metabolic Disorders
LPS-mediated signaling in adipose tissue macrophages regulates postprandial glycemia through Akt-mTOR activation. This connects chronic low-grade inflammation to insulin resistance and type 2 diabetes. The pathway is a potential target for metabolic syndrome.
From lipopolysaccharide-mediated signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TLR4 mediate LPS-induced cytokine production? | TLR4 knockout macrophages |
| How does CD14 point mutation affect LPS sensitivity? | CD14 point-mutant cell line |
| Can we visualize NF-κB nuclear translocation in real time? | NF-κB-GFP knock-in reporter |
| What is the role of Akt-mTOR in LPS response in adipocytes? | Adipose-specific Akt1 overexpression |
| Does GDF5 inhibit pyroptosis via RhoA? | RhoA knockout nucleus pulposus cells |
| How does P2 purinoceptor regulate IL-6 mRNA? | P2RY2 overexpression in dental pulp cells |
How to Study the lipopolysaccharide-mediated signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify LPS-induced transcriptional programs |
| Phosphoproteomics | Phosphorylation of signaling proteins | Map kinase activation |
| Live-cell imaging | NF-κB nuclear translocation | Real-time pathway dynamics |
| ELISA | Cytokine secretion | Functional validation of pathway activity |
| Western blot | Protein levels and phosphorylation | Confirm knockout/overexpression |
| CRISPR screening | Gene essentiality in LPS response | Identify novel regulators |
| Flow cytometry | Surface marker expression | Immune cell activation |
Transcriptomic Profiling (RNA-seq)
RNA sequencing measures global transcriptional changes following LPS stimulation, identifying NF-κB target genes and pathway activation signatures. It is widely used to dissect the LPS response in macrophages and endothelial cells.
Phosphoproteomics
Phosphoproteomics captures the dynamic phosphorylation events in the TLR4 signaling cascade, including MAPK and Akt activation. This method reveals kinase activity and crosstalk nodes.
Imaging of NF-κB Translocation
Live-cell imaging with fluorescently tagged NF-κB (e.g., p65-GFP) allows real-time monitoring of nuclear translocation after LPS stimulation. This provides spatial and temporal resolution of pathway activation.
Cytokine Secretion Assays
ELISA and multiplex assays quantify secreted cytokines such as TNF-α, IL-6, and IL-1β, serving as functional readouts of LPS-mediated signaling. These are standard for validating pathway perturbations.
How CRISPR Can Be Used to Study GO:0031663 lipopolysaccharide-mediated signaling pathway
Knockout
CRISPR knockout of TLR4, CD14, or NFKB1 in macrophage cell lines abolishes LPS-mediated signaling, providing causal evidence for their roles. EDITGENE offers validated KO pools and clones for these targets.
Point Mutation
Introducing point mutations in CD14 or TLR4 (e.g., in the LPS-binding domain) allows fine mapping of receptor-ligand interactions. EDITGENE provides precise point-mutant cell lines to study signaling thresholds.
Knock-in
Knock-in of fluorescent reporters (e.g., NF-κB-GFP) enables real-time visualization of pathway activation in live cells. EDITGENE can generate tagged knock-in lines for dynamic studies.
Overexpression
Overexpression of constitutively active Akt1 or RhoA mimics LPS-induced metabolic or pyroptotic responses. EDITGENE provides stable overexpression lines for gain-of-function studies.
How EDITGENE Supports lipopolysaccharide-mediated signaling pathway Research
Researchers studying lipopolysaccharide-mediated signaling pathway-related genes often need to determine whether a candidate gene is causally involved in LPS responses, and to dissect the precise molecular mechanisms. EDITGENE provides end-to-end CRISPR solutions to generate the exact cell models required for such investigations.
Contact EDITGENE today to design your custom CRISPR model for lipopolysaccharide-mediated signaling pathway research.
Frequently Asked Questions About lipopolysaccharide-mediated signaling pathway
What is the lipopolysaccharide-mediated signaling pathway?
It is the series of molecular signals initiated by LPS binding to cell surface receptors, leading to regulation of downstream processes such as transcription.
What genes are involved in lipopolysaccharide-mediated signaling pathway?
Key genes include TLR4, CD14, LY96 (MD-2), NFKB1, MAPK1/3, AKT1, MTOR, and P2RY2, among others.
What is the role of TLR4 in LPS signaling?
TLR4 is the primary receptor that recognizes LPS and initiates the signaling cascade, leading to NF-κB activation.
How does LPS activate NF-κB?
LPS binding to TLR4 recruits adaptor proteins, activating kinases that phosphorylate and degrade IκB, allowing NF-κB to enter the nucleus.
What diseases are associated with LPS-mediated signaling?
Acute lung injury, sepsis, atherosclerosis, neuroinflammation, and metabolic disorders such as insulin resistance.
How can I study LPS-mediated signaling using CRISPR?
CRISPR knockout, point mutation, knock-in reporters, and overexpression models allow precise interrogation of pathway components.
What is the role of CD14 in LPS signaling?
CD14 is a co-receptor that facilitates LPS transfer to TLR4/MD-2 complex, enhancing sensitivity to LPS.
Does LPS signaling crosstalk with metabolic pathways?
Yes, LPS signaling intersects with Akt-mTOR in adipose tissue macrophages, influencing postprandial glycemia.
What is the role of purinergic signaling in LPS response?
ATP-mediated signaling via P2 purinoceptors regulates IL-6 mRNA expression in dental pulp cells.
How does GDF5 affect LPS-mediated pyroptosis?
GDF5 inhibits LPS-mediated pyroptosis of nucleus pulposus mesenchymal stem cells via RhoA signaling.
Conclusion
The lipopolysaccharide-mediated signaling pathway (GO:0031663) is a central mechanism of innate immunity and inflammation, with broad implications for human health and disease. Understanding its molecular players and regulatory nodes offers opportunities for therapeutic intervention in inflammatory and metabolic disorders. CRISPR-based models are indispensable for dissecting this pathway, and EDITGENE provides comprehensive services to support such research.
References
- 1. Jin J et al.. 2019. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.. J Surg Res 235:83-92 PMID: 30691855
- 2. Zhang Z et al.. 2019. N‑acetyl cysteine protects HUVECs against lipopolysaccharide‑mediated inflammatory reaction by blocking the NF‑κB signaling pathway.. Mol Med Rep 20(5):4349-4357 PMID: 31545445
- 3. Orimoto A et al.. 2024. Lipopolysaccharide-mediated ATP signaling regulates interleukin-6 mRNA expression via the P2-purinoceptor in human dental pulp cells.. Cell Biol Int 48(3):369-377 PMID: 38225667
- 4. Qing W et al.. 2025. Wnt1 oversees microglial activation by the Wnt/LRP5/6 receptor signaling pathway during lipopolysaccharide-mediated toxicity.. Mol Biol Rep 52(1):273 PMID: 40025242
- 5. Toda G et al.. 2020. Insulin- and Lipopolysaccharide-Mediated Signaling in Adipose Tissue Macrophages Regulates Postprandial Glycemia through Akt-mTOR Activation.. Mol Cell 79(1):43-53.e4 PMID: 32464093
- 6. Hsu JC et al.. 2024. Transient receptor potential vanilloid 1 interacts with Toll-like receptor 4 (TLR4)/cluster of differentiation 14 (CD14) signaling pathway in lipopolysaccharide-mediated inflammation in macrophages.. Exp Anim 73(3):336-346 PMID: 38508727
- 7. Zhu C et al.. 2023. Growth differentiation factor 5 inhibits lipopolysaccharide-mediated pyroptosis of nucleus pulposus mesenchymal stem cells via RhoA signaling pathway.. Mol Biol Rep 50(8):6337-6347 PMID: 37310547
- 8. Chen X et al.. 2024. Selenomethionine alleviates kidney necroptosis and inflammation by restoring lipopolysaccharide-mediated mitochondrial dynamics imbalance via the TLR4/RIPK3/DRP1 signaling pathway in laying hens.. Poult Sci 103(12):104439 PMID: 39504830
